UBS Maintains Neutral on Incyte, Raises Price Target to $113
Incyte Corporation
Incyte Corporation INCY | 0.00 |
UBS analyst Ashwani Verma maintains Incyte (NASDAQ:
INCY) with a Neutral and raises the price target from $103 to $113.
UBS Maintains Neutral on Incyte, Raises Price Target to $113
Incyte Corporation INCY | 0.00 |